Estrogen-induced apoptosis of breast epithelial cells is blocked by NO/cGMP and mediated by extranuclear estrogen receptors

Endocrinology

Volumn 151, Issue 12, 2010, Pages 5602-5616

  Kastrati, Irida ^a   Edirisinghe, Praneeth D ^a   Wijewickrama, Gihani T ^a   Thatcher, Gregory R J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE 3; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; SERINE; TYRPHOSTIN;

APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; MITOCHONDRION; PRIORITY JOURNAL;

APOPTOSIS; BREAST; CASPASE 3; CELL LINE; CULTURE MEDIA, SERUM-FREE; CYCLIC GMP; EPITHELIAL CELLS; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 78649824765     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0378     Document Type: Article

References (88)

1. Lancaster Jr JR 1997 A tutorial on the diffusibility and reactivity of free nitric oxide. Nitric Oxide 1:18-30
2. Iwakiri Y, Satoh A, Chatterjee S, Toomre DK, Chalouni CM, Fulton D, Groszmann RJ, Shah VH, Sessa WC 2006 Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc Natl Acad Sci USA 103: 19777-19782
3. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM 2002 Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416:337-339
4. Kim SF, Huri DA, Snyder SH 2005 Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310: 1966-1970
5. Thomas DD, Espey MG, Ridnour LA, Hofseth LJ, Mancardi D, Harris CC, Wink DA 2004 Hypoxic inducible factor 1α, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc Natl Acad Sci USA 101:8894-8899
6. Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, Donzelli S, Hussain P, Vecoli C, Paolocci N, Ambs S, Colton CA, Harris CC, Roberts DD, Wink DA 2008 The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45:18-31
7. Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S 2004 Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem 279:36167-36170
8. Ambs S, Merriam WG, Ogunfusika MO, Bennett WP, Ishibe N, Hussain SP, Tzeng EE, Geller DA, Billiar TR, Harris CC 1998 p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells. Nat Med 4:1371-1376 (Pubitemid 28553458)
9. Pervin S, Chaudhuri G, Singh R 2010 NO to breast: when, why and why not? Curr Pharm Des 16:451-462
10. Kim YM, Bombeck CA, Billiar TR 1999 Nitric oxide as a bifunctional regulator of apoptosis. Circ Res 84:253-256
11. Yu Z, Kuncewicz T, Dubinsky WP, Kone BC 2006 Nitric oxide-dependent negative feedback of PARP-1 trans-activation of the inducible nitric-oxide synthase gene. J Biol Chem 281:9101-9109
12. Key T, Appleby P, Barnes I, Reeves G 2002 Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616
13. Banks E, Canfell K 2009 Invited commentary: hormone therapy risks and benefits-the Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Am J Epidemiol 170: 24-28
14. Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL 2008 Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol 167:1407-1415
15. Wang TT, Phang JM 1995 Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55:2487-2489
16. Perillo B, Sasso A, Abbondanza C, Palumbo G 2000 17β-Estradiol inhibits apoptosis in MCF-7 cells, inducing bcl-2 expression via two estrogen-responsive elements present in the coding sequence. Mol Cell Biol 20:2890-2901
17. Kim JK, Pedram A, Razandi M, Levin ER 2006 Estrogen prevents cardiomyocyte apoptosis through inhibition of reactive oxygen species and differential regulation of p38 kinase isoforms. J Biol Chem 281:6760-6767
18. Patten RD, Pourati I, Aronovitz MJ, Baur J, Celestin F, Chen X, Michael A, Haq S, Nuedling S, Grohe C, Force T, Mendelsohn ME, Karas RH 2004 17β-Estradiol reduces cardiomyocyte apoptosis in vivo and in vitro via activation of phospho-inositide-3 kinase/Akt signaling. Circ Res 95:692-699
19. Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W 2009 Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Ann NY Acad Sci 1155:132-140
20. Burdick AD, Ivnitski-Steele ID, Lauer FT, Burchiel SW 2006 PYK2 mediates anti-apoptotic AKT signaling in response to benzo- [a]pyrene diol epoxide in mammary epithelial cells. Carcinogenesis 27:2331-2340
21. Marella NV, Malyavantham KS, Wang J, Matsui S, Liang P, Berezney R 2009 Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines. Cancer Res 69:5946-5953
22. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME 1997 Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665
23. Ghayad SE, Vendrell JA, Larbi SB, Dumontet C, Bieche I, Cohen PA 2010 Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways. Int J Cancer 126:545-562
24. Furfine ES, Harmon MF, Paith JE, Garvey EP 1993 Selective inhibition of constitutive nitric oxide synthase by L-NG-nitroarginine. Biochemistry 32:8512-8517
25. Pollock JS, Förstermann U, Mitchell JA, Warner TD, Schmidt HH, Nakane M, Murad F 1991 Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:10480-10484 (Pubitemid 21915859)
26. Klatt P, Schmidt K, Brunner F, Mayer B 1994 Inhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation. J Biol Chem 269:1674-1680
27. Garvey EP, Tuttle JV, Covington K, Merrill BM, Wood ER, Baylis SA, Charles IG 1994 Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 311:235-241
28. Narayanan K, Griffith OW 1994 Synthesis of L-thiocitrulline, L-homothiocitrulline, and S-methyl-L-thiocitrulline: a new class of potent nitric oxide synthase inhibitors. J Med Chem 37:885-887
29. Erdal EP, Litzinger EA, Seo J, Zhu Y, Ji H, Silverman RB 2005 Selective neuronal nitric oxide synthase inhibitors. Curr Top Med Chem 5:603-624
30. Kim HY, Sohn J, Wijewickrama GT, Edirisinghe P, Gherezghiher T, Hemachandra M, Lu PY, Chandrasena RE, Molloy ME, Tonetti DA, Thatcher GR 2010 Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogens. Bioorg Med Chem 18:809-821
31. Dennis MK, Burai R, Ramesh C, Petrie WK, Alcon SN, Nayak TK, Bologa CG, Leitao A, Brailoiu E, Deliu E, Dun NJ, Sklar LA, Hathaway HJ, Arterburn JB, Oprea TI, Prossnitz ER 2009 In vivo effects of a GPR30 antagonist. Nat Chem Biol 5:421-427
32. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schröder H, Stahl E, Steinke W, Wunder F 2002 NO-and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol 136:773-783
33. Xu H, Freitas MA 2007 A mass accuracy sensitive probability based scoring algorithm for database searching of tandem mass spectrometry data. BMC Bioinformatics 8:133
34. Xu H, Freitas MA 2009 Mass Matrix: a database search program for rapid characterization of proteins and peptides from tandem mass spectrometry data. Proteomics 9:1548-1555
35. Merlo GR, Basolo F, Fiore L, Duboc L, Hynes NE 1995 p53-Dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J Cell Biol 128:1185-1196
36. Merto GR, Cella N, Hynes NE 1997 Apoptosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment, and inhibited by specific extracellular matrix proteins in mammary epithelial cells. Cell Growth Differ 8:251-260
37. Kennedy SG, Wagner AJ, Conzen SD, Jordán J, Bellacosa A, Tsichlis PN, Hay N 1997 The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11:701-713
38. Ahmad S, Singh N, Glazer RI 1999 Role of AKT1 in 17β-estradiol-and insulin-like growth factor I (IGF-I)-dependent proliferation and prevention of apoptosis in MCF-7 breast carcinoma cells. Biochem Pharmacol 58:425-430
39. Ghatan S, Larner S, Kinoshita Y, Hetman M, Patel L, Xia Z, Youle RJ, Morrison RS 2000 p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J Cell Biol 150:335-347
40. Kim SJ, Ju JW, Oh CD, Yoon YM, Song WK, Kim JH, Yoo YJ, Bang OS, Kang SS, Chun JS 2002 ERK-1/2 and p38 kinase oppositely regulate nitric oxide-induced apoptosis of chondrocytes in association with p53, caspase-3, and differentiation status. J Biol Chem 277:1332-1339
41. Chang M, Peng KW, Kastrati I, Overk CR, Qin ZH, Yao P, Bolton JL, Thatcher GRJ 2007 Activation of estrogen receptor-mediated gene transcription by the equine estrogen metabolite, 4-methoxyequilenin, in human breast cancer cells. Endocrinology 148: 4793-4802
42. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, Knowles RG 1997 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963
43. Furfine ES, Harmon MF, Paith JE, Knowles RG, Salter M, Kiff RJ, Duffy C, Hazelwood R, Oplinger JA, Garvey EP 1994 Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J Biol Chem 269:26677-26683
44. Qin Z, Kastrati I, Chandrasena RE, Liu H, Yao P, Petukhov PA, Bolton JL, Thatcher GRJ 2007 Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity. J Med Chem 50:2682-2692
45. Overk CR, Peng KW, Asghodom RT, Kastrati I, Lantvit DD, Qin Z, Frasor J, Bolton JL, Thatcher GRJ 2007 Structure-activity relationships for a family of benzothiophene selective estrogen receptor modulators including raloxifene and arzoxifene. ChemMedChem 2:1520-1526
46. Taguchi Y, Koslowski M, Bodenner D 2004 Binding of estrogen receptor with estrogen conjugated to bovine serum albumin (BSA). Nucl Rec 2:5
47. Stevis PE, Deecher DC, Suhadolnik L, Mallis LM, Frail DE 1999 Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 140:5455-5458
48. Qiu J, Bosch MA, Tobias SC, Grandy DK, Scanlan TS, Ronnekleiv OK, Kelly MJ 2003 Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 23:9529-9540 (Pubitemid 37352053)
49. Marino M, Galluzzo P, Leone S, Acconcia F, Ascenzi P 2006 Nitric oxide impairs the 17β-estradiol-induced apoptosis in human colon adenocarcinoma cells. Endocr Relat Cancer 13:559-569 (Pubitemid 43890873)
50. Ciani E, Virgili M, Contestabile A 2002 Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurones. J Neurochem 81:218-228 (Pubitemid 34809347)
51. Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK 2006 Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/ cGMP pathway in human ovarian cancer cells. Oncogene 25:2203-2212
52. Chan SL, Fiscus RR 2003 Guanylyl cyclase inhibitors NS2028 and ODQ and protein kinase G (PKG) inhibitor KT5823 trigger apoptotic DNA fragmentation in immortalized uterine epithelial cells: anti-apoptotic effects of basal cGMP/PKG. Mol Hum Reprod 9:775-783
53. Kim YM, Chung HT, Kim SS, Han JA, Yoo YM, Kim KM, Lee GH, Yun HY, Green A, Li J, Simmons RL, Billiar TR 1999 Nitric oxide protects PC12 cells from serum deprivation-induced apoptosis by cGMP-dependent inhibition of caspase signaling. J Neurosci 19: 6740-6747
54. Gross A, McDonnell JM, Korsmeyer SJ 1999 BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911
55. Fiskum G 2000 Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma 17:843-855
56. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ 2004 Nitric oxide: a signaling molecule against mitochondrial permeability transition-and pH-dependent cell death after reperfusion. Free Radic Biol Med 37:1943-1950
57. Chen F, Arseven OK, Cryns VL 2004 Proteolysis of the mismatch repair protein MLH1 by caspase-3 promotes DNA damage-induced apoptosis. J Biol Chem 279:27542-27548
58. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC 1990 Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086 (Pubitemid 20331424)
59. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR 1998 Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19:291-298
60. Allred DC, Brown P, Medina D 2004 The origins of estrogen receptor α-positive and estrogen receptor α-negative human breast cancer. Breast Cancer Res 6:240-245
61. Chen JQ, Russo J 2009 ERα-negative and triple negative breast cancer: molecular features and potential therapeutic approaches. Biochim Biophys Acta 1796:162-175
62. Adam L, Crépin M, Isräel L 1997 Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination. Cancer Res 57:1023-1029
63. Somaï S, Chaouat M, Jacob D, Perrot JY, Rostène W, Forgez P, Gompel A 2003 Antiestrogens are pro-apoptotic in normal human breast epithelial cells. Int J Cancer 105:607-612
64. Lewis-Wambi JS, Jordan VC 2009 Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit? Breast Cancer Res 11:206
65. Boyan BD, Sylvia VL, Frambach T, Lohmann CH, Dietl J, Dean DD, Schwartz Z 2003 Estrogen-dependent rapid activation of protein kinase Cin estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen. Endocrinology 144:1812-1824
66. Helguero LA, Faulds MH, Gustafsson JA, Haldosén LA 2005 Estrogen receptors α (ERα) and β (ERβ) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24:6605-6616
67. Tsai EM, Wang SC, Lee JN, Hung MC 2001 Akt activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res 61:8390-8392
68. Levin ER 2001 Cell localization, physiology, and nongenomic actions of estrogen receptors. J Appl Physiol 91:1860-1867
69. Prossnitz ER, Maggiolini M 2009 Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 308:32-38
70. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS 1997 Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99:2429-2437
71. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S 1994 Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91:5212-5216 (Pubitemid 24177823)
72. García-Durán M, de Frutos T, Díaz-Recasens J, García-Gálvez G, Jiménez A, Montón M, Farré J, Sánchez de Miguel L, González- Fernández F, Arriero MD, Rico L, García R, Casado S, López-Farré A 1999 Estrogen stimulates neuronal nitric oxide synthase protein expression in human neutrophils. Circ Res 85:1020-1026
73. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
74. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, Karas RH 2004 Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor α. Proc Natl Acad Sci USA 101:17126-17131
75. Acconcia F, Totta P, Ogawa S, Cardillo I, Inoue S, Leone S, Trentalance A, Muramatsu M, Marino M 2005 Survival versus apoptotic 17β-estradiol effect: role of ERα and ERβ activated non-genomic signaling. J Cell Physiol 203:193-201
76. Prueitt RL, Boersma BJ, Howe TM, Goodman JE, Thomas DD, Ying L, Pfiester CM, Yfantis HG, Cottrell JR, Lee DH, Remaley AT, Hofseth LJ, Wink DA, Ambs S 2007 Inflammation and IGF-I activate the Akt pathway in breast cancer. Int J Cancer 120:796-805
77. Kim PK, Zamora R, Petrosko P, Billiar TR 2001 The regulatory role of nitric oxide in apoptosis. Int Immunopharmacol 1:1421-1441
78. Li J, Billiar TR, Talanian RV, Kim YM 1997 Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun 240:419-424
79. Li J, Yang S, Billiar TR 2000 Cyclic nucleotides suppress tumor necrosis factor α-mediated apoptosis by inhibiting caspase activation and cytochrome c release in primary hepatocytes via a mechanism independent of Akt activation. J Biol Chem 275:13026-13034
80. Kim YM, Talanian RV, Billiar TR 1997 Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272:31138-31148
81. Estévez AG, Spear N, Thompson JA, Cornwell TL, Radi R, Barbeito L, Beckman JS 1998 Nitric oxide-dependent production of cGMP supports the survival of rat embryonic motor neurons cultured with brain-derived neurotrophic factor. J Neurosci 18:3708-3714
82. Frame S, Cohen P 2001 GSK3 takes centre stage more than 20 years after its discovery. Biochem J 359:1-16
83. Kim JS, Ohshima S, Pediaditakis P, Lemasters JJ 2004 Nitric oxide protects rat hepatocytes against reperfusion injury mediated by the mitochondrial permeability transition. Hepatology 39:1533-1543
84. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, Carruba MO 2003 Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299:896-899
85. Kim JS, Nitta T, Mohuczy D, O'Malley KA, Moldawer LL, Dunn Jr WA, Behrns KE 2008 Impaired autophagy: a mechanism of mitochondrial dysfunction in anoxic rat hepatocytes. Hepatology 47: 1725-1736
86. Green DR 2005 Apoptotic pathways: ten minutes to dead. Cell 121: 671-674
87. Chen JQ, Brown TR, Yager JD 2008 Mechanisms of hormone carcinogenesis: evolution of views, role of mitochondria. Adv Exp Med Biol 630:1-18
88. Martin JH, Alalami O, van den Berg HW 1999 Reduced expression of endothelial and inducible nitric oxide synthase in a human breast cancer cell line which has acquired estrogen independence. Cancer Lett 144:65-74